Paul Newhouse
Committed to Memory: VU319 may hold the key to improving memory loss in Alzheimer’s patients
Jul. 23, 2020—VU319, an investigational drug product developed by Vanderbilt researchers, targets one of medicine’s most bedeviling challenges: improving memory loss in people with Alzheimer’s disease.
Vanderbilt, The Ohio State University developing ‘socially assistive robots’ to stem loneliness and encourage activity among aging
Jun. 18, 2020—Prestigious grant awarded to Nilanjan Sarkar, Vanderbilt researcher developing social robotics to stymie apathy among older adults.
Study explores nicotine patch to treat mild cognitive impairment
Nov. 2, 2017—Three years ago Reece Dean, of Nashville’s Bellevue community, retired at age 69 from a career as a busy truck driver. Mary Ann, his wife, began to notice some changes in his memory and behavior since he was home more consistently.
Vanderbilt begins Phase 1 trials of new Alzheimer’s drug
Aug. 7, 2017—Developed at Vanderbilt, VU319 is designed to precisely target a specific neuron receptor associated with cognitive function while avoiding potentially dangerous side effects.
Clues found to recurrent depression
Mar. 2, 2017—Women who have had repeated depressive episodes tend to pay more attention to negative emotional information, suggesting that they may benefit from cognitive therapy to build new, more positive pathways in their brains.
Investigational new drug for Alzheimer’s scheduled for first study in humans
Dec. 27, 2016—Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.
Study explores nicotine patch to treat memory loss
Oct. 29, 2015—Vanderbilt University Medical Center has received a $9.4 million grant from the National Institute on Aging (NIA) to test the effectiveness of a transdermal nicotine patch in improving memory loss in older adults with mild cognitive impairment (MCI), a precursor to Alzheimer’s disease.
Cancer drug enhances cognition
Dec. 16, 2013—The breast cancer drug tamoxifen improves cognitive performance in post-menopausal women.
Vanderbilt celebrates 18 elected fellows of the AAAS
Nov. 25, 2013—Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
New endowed chair holders recognized
Dec. 20, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements last week during a celebration at the Student Life Center. “An endowed chair is the highest academic honor that a university can bestow on its faculty,” said University Provost and Vice Chancellor for Academic Affairs Richard McCarty, Ph.D. “It’s really...
Nine faculty honored at endowed chair celebration
Dec. 13, 2012—Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center.
Academic Minute: Nicotine and memory
May. 30, 2012—Paul Newhouse, Jim Turner Professor of Cognitive Disorders, is interviewed about his research showing that nicotine can help boost memory in people with mild cognitive impairment.